Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Buy
Exponential Moving Average
Buy
Relative Strength Index
Neutral
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
NRX Pharmaceuticals, Inc. Common Stock (NRXP)
Pharmaceutical Preparations
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.
1201 ORANGE STREET, SUITE 600
WILMINGTON, DE
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/25/2021
Market Cap
18,940,078
Shares Outstanding
85,170,000
Weighted SO
85,167,479
Total Employees
N/A
Upcoming Earnings
08/12/2024
Similar Tickers
Beta
1.2600
Last Div
0.0000
Range
1.73-7.33
Chg
0.0300
Avg Vol
98043
Mkt Cap
18940078
Exch
NASDAQ
Country
US
Phone
484 254 6134
DCF Diff
2.3427
DCF
-0.6027
Div Yield
0.0000
P/S
2367.5098
EV Multiple
-1.1080
P/FV
-1.0122
Div Yield %
0.0000
P/E
-0.7501
PEG
0.0012
Payout
0.0000
Current Ratio
0.2063
Quick Ratio
0.2063
Cash Ratio
0.0802
DSO
273.7500
DIO
0.0000
Op Cycle
273.7500
DPO
366095.0000
CCC
-365821.2500
Gross Margin
0.3750
Op Margin
-2907.7500
Pretax Margin
-3102.3750
Net Margin
-3102.3750
Eff Tax Rate
0.0563
ROA
-4.7149
ROE
1.9311
ROCE
1.2649
NI/EBT
1.0000
EBT/EBIT
1.0669
EBIT/Rev
-2907.7500
Debt Ratio
1.6326
D/E
-0.4673
LT Debt/Cap
0.0000
Total Debt/Cap
-0.8772
Int Coverage
-66.4629
CF/Debt
-1.7375
Equity Multi
-0.2862
Rec Turnover
1.3333
Pay Turnover
0.0010
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0015
OCF/Share
-1.4197
FCF/Share
-1.4195
Cash/Share
0.1805
OCF/Sales
-1866.5000
FCF/OCF
0.9999
CF Coverage
-1.7375
ST Coverage
-1.7375
CapEx Coverage
-7466.0000
Div&CapEx Cov
-7466.0000
P/BV
-1.0122
P/B
-1.0122
P/S
2367.5098
P/E
-0.7501
P/FCF
-1.2686
P/OCF
-1.2467
P/CF
-1.2467
PEG
0.0012
P/S
2367.5098
EV Multiple
-1.1080
P/FV
-1.0122
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
50.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
40.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 8.00K | ▼ 0.00 |
Cost Of Revenue | 1.01M | ▼ 0.00 | ▲ 907.41K | ▼ 0.00 | ▲ 1.00K | 1.00K | 1.00K |
Gross Profit | -1.01M | ▲ 0.00 | ▼ -907.41K | ▲ 0.00 | ▼ -1.00K | ▲ 7.00K | ▼ -1.00K |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.88 | ▼ 0.00 |
Research And Development Expenses | 0.00 | 0.00 | ▲ 4.30M | ▲ 6.41M | ▼ 4.46M | ▼ 2.53M | ▼ 1.75M |
General And Administrative Expenses | 322.08K | ▼ 163.18K | ▲ 6.54M | ▲ 46.56M | ▼ 5.43M | ▼ 1.87M | ▲ 4.25M |
Selling And Marketing Expenses | 0.00 | ▲ 27.78K | ▼ 0.00 | ▲ 13.81B | ▼ 0.00 | ▼ -1.00K | -1.00K |
Selling General And Administrative Expenses | 322.08K | ▼ 190.96K | ▲ 6.54M | ▲ 46.56M | ▼ 5.43M | ▼ 1.87M | ▲ 4.25M |
Other Expenses | 0.00 | ▲ 713.19K | ▲ 3.93M | ▼ -359.00 | ▲ 0.00 | ▲ 2.27M | ▼ 0.00 |
Operating Expenses | 322.08K | ▼ 190.96K | ▲ 5.64M | ▲ 52.98M | ▼ 9.89M | ▼ 4.41M | ▲ 6.00M |
Cost And Expenses | 322.08K | ▼ 190.96K | ▲ 5.64M | ▲ 52.98M | ▼ 9.89M | ▼ 4.41M | ▲ 6.00M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 130.00K | ▼ 74.00K | ▼ 27.00K |
Interest Expense | 0.00 | 0.00 | ▲ 4.68K | ▼ 2.34K | ▼ -3.00K | ▲ 80.00K | ▲ 230.00K |
Depreciation And Amortization | 319.47K | ▼ 172.28K | ▼ 890.00 | ▼ 395.00 | ▼ -374.00K | ▲ 1.00K | 1.00K |
Ebitda | -2.60K | ▼ -18.68K | ▼ -45.12M | ▼ -52.98M | ▲ -10.26M | ▲ -4.41M | ▼ -6.00M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -100.00 | ▲ 0.00 |
Operating Income | -322.08K | ▲ -190.96K | ▼ -45.12M | ▼ -52.98M | ▲ -9.89M | ▲ -4.41M | ▼ -6.00M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -550.75 | ▲ 0.00 |
Total Other Income Expenses Net | 319.47K | ▼ 172.28K | ▼ -39.49M | ▲ 22.18M | ▼ -353.00K | ▲ 74.00K | ▼ -530.00K |
Income Before Tax | -2.60K | ▼ -18.68K | ▼ -45.13M | ▲ -30.79M | ▲ -10.24M | ▲ -4.33M | ▼ -6.53M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -100.00 | ▲ 0.00 |
Income Tax Expense | -31.74K | ▲ -3.92K | ▼ -5.36K | ▼ -5.35M | ▲ -4.52M | ▲ -1.39M | ▲ 0.00 |
Net Income | 29.14K | ▼ -14.75K | ▼ -45.13M | ▲ -30.79M | ▲ -5.72M | ▲ -4.33M | ▼ -6.53M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -100.00 | ▲ 0.00 |
Eps | 0.01 | ▼ -0.01 | ▼ -16.73 | ▲ -0.60 | ▲ -0.09 | ▲ -0.05 | ▼ -0.74 |
Eps Diluted | 0.01 | ▼ -0.01 | ▼ -16.73 | ▲ -0.60 | ▲ -0.09 | ▲ -0.05 | ▼ -0.74 |
Weighted Average Shs Out | 2.73M | ▲ 2.84M | ▼ 2.70M | ▲ 51.74M | ▲ 66.45M | ▲ 83.92M | ▼ 8.85M |
Weighted Average Shs Out Dil | 2.73M | ▲ 2.84M | ▼ 2.70M | ▲ 51.74M | ▲ 66.45M | ▲ 83.92M | ▼ 8.85M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 11.08K | ▼ 6.00 | ▲ 1.86M | ▲ 27.61M | ▼ 20.05M | ▼ 4.60M | ▼ 1.32M |
Short Term Investments | 70.77M | ▼ 32.01M | ▼ 5.97M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 11.08K | ▼ 6.00 | ▲ 1.86M | ▲ 27.61M | ▼ 20.05M | ▼ 4.60M | ▼ 1.32M |
Net Receivables | 0.00 | 0.00 | ▲ 831.00K | ▼ 0.00 | ▲ 7.00K | ▼ 6.00K | 6.00K |
Inventory | 0.00 | 0.00 | ▲ 214.00K | ▼ 0.00 | ▼ -7.00K | ▲ -6.00K | ▲ 0.00 |
Other Current Assets | 19.11K | ▲ 69.48K | ▼ 26.00K | ▲ 5.11M | ▲ 5.74M | ▼ 2.29M | ▼ 2.02M |
Total Current Assets | 30.19K | ▲ 69.49K | ▲ 2.93M | ▲ 32.71M | ▼ 25.80M | ▼ 6.88M | ▼ 3.35M |
Property Plant Equipment Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 71.00M | ▼ 32.00M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | -234.03K | ▲ 5.21K | ▲ 11.00K | ▲ 15.00K | ▲ 21.00K | ▲ 431.00K | ▲ 441.00K |
Total Non Current Assets | 70.77M | ▼ 32.01M | ▼ 11.00K | ▲ 15.00K | ▲ 21.00K | ▲ 431.00K | ▲ 441.00K |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 70.80M | ▼ 32.07M | ▼ 2.94M | ▲ 32.73M | ▼ 25.82M | ▼ 7.32M | ▼ 3.79M |
Account Payables | 551.10K | ▲ 622.44K | ▲ 3.15M | ▲ 3.69M | ▼ 2.08M | ▲ 4.63M | ▲ 6.27M |
Short Term Debt | 0.00 | 0.00 | ▲ 249.00K | ▲ 518.00K | ▲ 7.70M | ▲ 9.16M | ▼ 6.78M |
Tax Payables | 16.31K | ▲ 69.48K | ▼ 51.64K | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | 0.00 | ▲ 43.96M | ▼ 2.84M | ▼ 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 16.31K | ▼ 0.00 | ▼ -1.20M | ▲ 4.87M | ▲ 5.81M | ▼ 5.26M | ▲ 5.81M |
Total Current Liabilities | 567.41K | ▲ 622.44K | ▲ 46.16M | ▼ 11.92M | ▲ 15.59M | ▲ 19.05M | ▼ 18.86M |
Long Term Debt | 690.00K | ▲ 1.95M | ▼ 548.00K | ▼ 0.00 | ▲ 2.82M | ▼ 0.00 | 0.00 |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 0.00 | 0.00 | 0.00 | ▲ 4.21M | ▼ 0.00 | 0.00 | ▲ 12.59M |
Total Non Current Liabilities | 690.00K | ▲ 1.95M | ▼ 548.00K | ▲ 4.21M | ▼ 2.82M | ▼ 0.00 | ▲ 12.59M |
Other Liabilities | 0.00 | 0.00 | 0.00 | ▼ -4.21M | ▲ 0.00 | 0.00 | ▼ -12.59M |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 1.26M | ▲ 2.57M | ▲ 46.71M | ▼ 11.92M | ▲ 18.41M | ▲ 19.05M | ▼ 18.86M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 3.00K | ▼ 0.00 |
Common Stock | 64.54M | ▼ 24.50M | ▼ 43.00K | ▲ 59.00K | ▲ 67.00K | ▲ 84.00K | ▼ 10.00K |
Retained Earnings | -38.93K | ▲ 369.50K | ▼ -90.18M | ▼ -183.24M | ▼ -223.00M | ▼ -253.15M | ▼ -259.68M |
Accumulated Other Comprehensive Income Loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -3.00K | -3.00K |
Other Total Stockholders Equity | 5.04M | ▼ 4.63M | ▲ 46.37M | ▲ 203.99M | ▲ 230.34M | ▲ 241.33M | ▲ 244.60M |
Total Stockholders Equity | 69.54M | ▼ 29.50M | ▼ -43.77M | ▲ 20.81M | ▼ 7.41M | ▼ -11.73M | ▼ -15.07M |
Total Equity | 69.54M | ▼ 29.50M | ▼ -43.77M | ▲ 20.81M | ▼ 7.41M | ▼ -11.73M | ▼ -15.07M |
Total Liabilities And Stockholders Equity | 70.80M | ▼ 32.07M | ▼ 2.94M | ▲ 32.73M | ▼ 25.82M | ▼ 7.32M | ▼ 3.79M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 70.80M | ▼ 32.07M | ▼ 2.94M | ▲ 32.73M | ▼ 25.82M | ▼ 7.32M | ▼ 3.79M |
Total Investments | 141.77M | ▼ 64.01M | ▼ 5.97M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 690.00K | ▲ 1.95M | ▼ 797.00K | ▼ 518.00K | ▲ 10.53M | ▼ 9.16M | ▼ 6.78M |
Net Debt | 678.92K | ▲ 1.95M | ▼ -1.06M | ▼ -27.09M | ▲ -9.53M | ▲ 4.57M | ▲ 5.46M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | 29.14K | ▼ -14.75K | ▼ -45.13M | ▲ -30.79M | ▲ -10.24M | ▲ -4.33M | ▼ -6.53M |
Depreciation And Amortization | 0.00 | 0.00 | ▲ 890.00 | ▼ 395.00 | ▲ 1.00K | 1.00K | 1.00K |
Deferred Income Tax | 0.00 | 0.00 | ▲ 2.69M | ▼ 0.00 | 0.00 | ▲ 2.20M | ▼ 0.00 |
Stock Based Compensation | 0.00 | 0.00 | ▲ 356.98K | ▲ 1.57M | ▼ 766.00K | ▼ 0.00 | ▲ 242.00K |
Change In Working Capital | -285.46K | ▲ -119.24K | ▲ 2.11M | ▼ -937.76K | ▲ 670.00K | ▲ 2.42M | ▼ 2.29M |
Accounts Receivables | 0.00 | 0.00 | ▲ 423.09K | ▼ -390.00 | ▲ 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | ▲ 2.36M | ▼ -814.58K | ▲ 0.00 | 0.00 | 0.00 |
Accounts Payables | 223.58K | ▼ 85.14K | ▼ -147.18K | ▼ -1.87M | ▲ -92.00K | ▲ 1.00M | ▲ 2.09M |
Other Working Capital | -509.03K | ▲ -204.37K | ▼ -527.05K | ▲ 1.75M | ▼ 762.00K | ▲ 1.42M | ▼ 196.00K |
Other Non Cash Items | 185.44K | ▼ -128.08K | ▲ 39.56M | ▼ 18.88M | ▼ 486.00K | ▼ -2.28M | ▲ -1.52M |
Net Cash Provided By Operating Activities | -70.88K | ▼ -262.07K | ▼ -406.71K | ▼ -11.28M | ▲ -8.32M | ▲ -3.19M | ▼ -3.67M |
Investments In Property Plant And Equipment | 0.00 | 0.00 | ▼ -2.00K | ▲ -388.00 | ▲ 1.00K | ▲ 4.00K | ▼ 0.00 |
Acquisitions Net | 0.00 | 0.00 | ▲ 25.96M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | ▼ -138.95K | ▲ 192.52K | ▼ 0.00 | ▼ -10.00K | ▲ -3.00K | ▲ 0.00 |
Sales Maturities Of Investments | 4.88K | ▲ 9.78M | ▼ -26.12M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -690.00K | ▲ 0.00 | ▼ -33.17K | ▲ 0.00 | ▲ 10.00K | ▼ -3.00K | ▲ 0.00 |
Net Cash Used For Investing Activities | -685.12K | ▲ 9.64M | ▼ -2.00K | ▲ -388.00 | ▲ 1.00K | 1.00K | ▼ 0.00 |
Debt Repayment | 0.00 | ▼ -65.00K | ▲ -35.00K | ▲ -474.00 | ▼ -10.02M | ▲ -1.12M | ▼ -2.16M |
Common Stock Issued | 0.00 | 0.00 | ▲ 989.90K | ▼ 878.00 | ▲ 92.00K | ▼ -8.12M | ▲ 2.55M |
Common Stock Repurchased | 0.00 | ▼ -9.74M | ▲ 26.30M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | ▼ -26.53M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 690.00K | ▼ 224.75K | ▲ 255.67K | ▼ 831.00 | ▲ 20.05M | ▼ 10.37M | ▼ -1.13M |
Net Cash Used Provided By Financing Activities | 690.00K | ▼ -9.58M | ▲ 980.37K | ▼ 1.24K | ▲ 10.12M | ▼ -1.12M | ▲ 395.00K |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | ▼ -611.22K | ▼ -1.85M | ▲ 0.00 | ▲ 7.18M | ▼ 0.00 |
Net Change In Cash | -66.01K | ▼ -194.27K | ▲ 571.24K | ▼ -11.28M | ▲ 1.81M | ▼ -4.31M | ▲ -3.28M |
Cash At End Of Period | 11.08K | ▼ 6.00 | ▲ 1.86M | ▲ 27.61M | ▼ 20.05M | ▼ 4.60M | ▼ 1.32M |
Cash At Beginning Of Period | 77.09K | ▲ 194.28K | ▲ 1.29M | ▲ 38.88M | ▼ 18.25M | ▼ 8.90M | ▼ 4.60M |
Operating Cash Flow | -70.88K | ▼ -262.07K | ▼ -406.71K | ▼ -11.28M | ▲ -8.32M | ▲ -3.19M | ▼ -3.67M |
Capital Expenditure | 0.00 | 0.00 | ▼ -2.00K | ▲ -388.00 | ▲ 1.00K | ▲ 4.00K | ▼ 0.00 |
Free Cash Flow | -70.88K | ▼ -262.07K | ▼ -408.71K | ▼ -11.28M | ▲ -8.32M | ▲ -3.19M | ▼ -3.67M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)